JPWO2021080950A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021080950A5 JPWO2021080950A5 JP2022523522A JP2022523522A JPWO2021080950A5 JP WO2021080950 A5 JPWO2021080950 A5 JP WO2021080950A5 JP 2022523522 A JP2022523522 A JP 2022523522A JP 2022523522 A JP2022523522 A JP 2022523522A JP WO2021080950 A5 JPWO2021080950 A5 JP WO2021080950A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- level
- sample
- protein
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000090 biomarker Substances 0.000 claims 128
- 239000000523 sample Substances 0.000 claims 37
- 239000004480 active ingredient Substances 0.000 claims 25
- 201000005787 hematologic cancer Diseases 0.000 claims 23
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 23
- 150000001875 compounds Chemical class 0.000 claims 15
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 101000941994 Homo sapiens Protein cereblon Proteins 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 230000001225 therapeutic effect Effects 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 8
- 108090000623 proteins and genes Proteins 0.000 claims 8
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 7
- 102100032783 Protein cereblon Human genes 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 102100021069 E3 ubiquitin-protein ligase ZFP91 Human genes 0.000 claims 5
- 239000013074 reference sample Substances 0.000 claims 5
- 241000673185 Aeolus Species 0.000 claims 4
- 108010012236 Chemokines Proteins 0.000 claims 4
- 102000019034 Chemokines Human genes 0.000 claims 4
- 102000004127 Cytokines Human genes 0.000 claims 4
- 108090000695 Cytokines Proteins 0.000 claims 4
- 101000818429 Homo sapiens E3 ubiquitin-protein ligase ZFP91 Proteins 0.000 claims 4
- 241000571697 Icarus Species 0.000 claims 4
- 102100036705 Interleukin-23 subunit alpha Human genes 0.000 claims 4
- 101710184597 Interleukin-23 subunit alpha Proteins 0.000 claims 4
- 102000004265 STAT2 Transcription Factor Human genes 0.000 claims 4
- 108010081691 STAT2 Transcription Factor Proteins 0.000 claims 4
- 230000006044 T cell activation Effects 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 210000000265 leukocyte Anatomy 0.000 claims 4
- 239000003550 marker Substances 0.000 claims 4
- 201000004085 CLL/SLL Diseases 0.000 claims 3
- 101000599042 Homo sapiens Zinc finger protein Aiolos Proteins 0.000 claims 3
- 102000017182 Ikaros Transcription Factor Human genes 0.000 claims 3
- 108010013958 Ikaros Transcription Factor Proteins 0.000 claims 3
- 102100030126 Interferon regulatory factor 4 Human genes 0.000 claims 3
- 102000014150 Interferons Human genes 0.000 claims 3
- 108010050904 Interferons Proteins 0.000 claims 3
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims 3
- -1 SERPINA Proteins 0.000 claims 3
- 102100037798 Zinc finger protein Aiolos Human genes 0.000 claims 3
- 239000013543 active substance Substances 0.000 claims 3
- 208000023738 chronic lymphocytic leukemia/small lymphocytic lymphoma Diseases 0.000 claims 3
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 229940079322 interferon Drugs 0.000 claims 3
- 108010051920 interferon regulatory factor-4 Proteins 0.000 claims 3
- 238000012544 monitoring process Methods 0.000 claims 3
- 230000002103 transcriptional effect Effects 0.000 claims 3
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims 2
- NZYDBVQXOGPDDU-HSZRJFAPSA-N 2-[(3R)-2,6-dioxopiperidin-3-yl]-4-[[2-fluoro-4-[(3-morpholin-4-ylazetidin-1-yl)methyl]phenyl]methylamino]isoindole-1,3-dione Chemical compound O=C1NC(CC[C@H]1N1C(C2=CC=CC(=C2C1=O)NCC1=C(C=C(C=C1)CN1CC(C1)N1CCOCC1)F)=O)=O NZYDBVQXOGPDDU-HSZRJFAPSA-N 0.000 claims 2
- NZYDBVQXOGPDDU-QHCPKHFHSA-N 2-[(3S)-2,6-dioxopiperidin-3-yl]-4-[[2-fluoro-4-[(3-morpholin-4-ylazetidin-1-yl)methyl]phenyl]methylamino]isoindole-1,3-dione Chemical compound O=C1NC(CC[C@@H]1N1C(C2=CC=CC(=C2C1=O)NCC1=C(C=C(C=C1)CN1CC(C1)N1CCOCC1)F)=O)=O NZYDBVQXOGPDDU-QHCPKHFHSA-N 0.000 claims 2
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 claims 2
- 108700012813 7-aminoactinomycin D Proteins 0.000 claims 2
- 102100037435 Antiviral innate immune response receptor RIG-I Human genes 0.000 claims 2
- 102000001765 Bcl-2-Like Protein 11 Human genes 0.000 claims 2
- 108010040168 Bcl-2-Like Protein 11 Proteins 0.000 claims 2
- 102100032920 Chromobox protein homolog 2 Human genes 0.000 claims 2
- 101710173113 Chromobox protein homolog 2 Proteins 0.000 claims 2
- 102100031265 Chromodomain-helicase-DNA-binding protein 2 Human genes 0.000 claims 2
- 101710170295 Chromodomain-helicase-DNA-binding protein 2 Proteins 0.000 claims 2
- 102100039518 Claudin-12 Human genes 0.000 claims 2
- 101710197000 Claudin-12 Proteins 0.000 claims 2
- 102000018156 Claudin-7 Human genes 0.000 claims 2
- 108050007296 Claudin-7 Proteins 0.000 claims 2
- 108010060682 DEAD Box Protein 58 Proteins 0.000 claims 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
- 108010024212 E-Selectin Proteins 0.000 claims 2
- 102100023471 E-selectin Human genes 0.000 claims 2
- 102100035134 Forkhead box protein J2 Human genes 0.000 claims 2
- 102100028122 Forkhead box protein P1 Human genes 0.000 claims 2
- 101710088095 Forkhead box protein P1 Proteins 0.000 claims 2
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 claims 2
- 101710142059 Free fatty acid receptor 2 Proteins 0.000 claims 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 2
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 2
- 101000615492 Homo sapiens Methyl-CpG-binding domain protein 4 Proteins 0.000 claims 2
- 101000795753 Homo sapiens mRNA decay activator protein ZFP36 Proteins 0.000 claims 2
- 102100027354 Interferon alpha-inducible protein 6 Human genes 0.000 claims 2
- 101710169201 Interferon alpha-inducible protein 6 Proteins 0.000 claims 2
- 102100040035 Interferon-induced transmembrane protein 3 Human genes 0.000 claims 2
- 101710087316 Interferon-induced transmembrane protein 3 Proteins 0.000 claims 2
- 102000003814 Interleukin-10 Human genes 0.000 claims 2
- 108090000174 Interleukin-10 Proteins 0.000 claims 2
- 108010002350 Interleukin-2 Proteins 0.000 claims 2
- 102000000588 Interleukin-2 Human genes 0.000 claims 2
- 108010066979 Interleukin-27 Proteins 0.000 claims 2
- 102100036678 Interleukin-27 subunit alpha Human genes 0.000 claims 2
- 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 claims 2
- 101710152369 Interleukin-6 receptor subunit beta Proteins 0.000 claims 2
- 102100040546 Lethal(3)malignant brain tumor-like protein 2 Human genes 0.000 claims 2
- 101710173075 Lethal(3)malignant brain tumor-like protein 2 Proteins 0.000 claims 2
- 102100040863 Lysine-specific demethylase 4A Human genes 0.000 claims 2
- 102100040860 Lysine-specific demethylase 4B Human genes 0.000 claims 2
- 102100033247 Lysine-specific demethylase 5B Human genes 0.000 claims 2
- 102000055120 MEF2 Transcription Factors Human genes 0.000 claims 2
- 108010018650 MEF2 Transcription Factors Proteins 0.000 claims 2
- 102100025169 Max-binding protein MNT Human genes 0.000 claims 2
- 102000044675 Methyl-CpG-binding domain protein 4 Human genes 0.000 claims 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 2
- 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 claims 2
- 108010054395 P-selectin ligand protein Proteins 0.000 claims 2
- 102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 claims 2
- 108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 claims 2
- 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 claims 2
- 102100037356 SLIT-ROBO Rho GTPase-activating protein 1 Human genes 0.000 claims 2
- 101710104382 SLIT-ROBO Rho GTPase-activating protein 1 Proteins 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 102100030628 Transcription factor 25 Human genes 0.000 claims 2
- 101710119686 Transcription factor 25 Proteins 0.000 claims 2
- 102100026154 Transcription factor AP-4 Human genes 0.000 claims 2
- 102100024207 Transcription factor COE1 Human genes 0.000 claims 2
- 102100034698 Transducin-like enhancer protein 3 Human genes 0.000 claims 2
- 101710101296 Transducin-like enhancer protein 3 Proteins 0.000 claims 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 2
- 102100027881 Tumor protein 63 Human genes 0.000 claims 2
- 101710140697 Tumor protein 63 Proteins 0.000 claims 2
- 102100040103 Upstream stimulatory factor 2 Human genes 0.000 claims 2
- 101710184190 Upstream stimulatory factor 2 Proteins 0.000 claims 2
- 102100040330 Zinc finger and BTB domain-containing protein 11 Human genes 0.000 claims 2
- 101710096183 Zinc finger and BTB domain-containing protein 11 Proteins 0.000 claims 2
- 102100026510 Zinc finger protein 644 Human genes 0.000 claims 2
- 101710182729 Zinc finger protein 644 Proteins 0.000 claims 2
- 102100035804 Zinc finger protein 823 Human genes 0.000 claims 2
- 210000002798 bone marrow cell Anatomy 0.000 claims 2
- 238000011443 conventional therapy Methods 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000012636 effector Substances 0.000 claims 2
- 108010046937 enhancer-binding protein AP-4 Proteins 0.000 claims 2
- 102000016557 gamma Subunit Interferon-Stimulated Gene Factor 3 Human genes 0.000 claims 2
- 108010067667 gamma Subunit Interferon-Stimulated Gene Factor 3 Proteins 0.000 claims 2
- 229940076144 interleukin-10 Drugs 0.000 claims 2
- 210000004698 lymphocyte Anatomy 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 210000000440 neutrophil Anatomy 0.000 claims 2
- 229960003347 obinutuzumab Drugs 0.000 claims 2
- 229960004641 rituximab Drugs 0.000 claims 2
- 230000011664 signaling Effects 0.000 claims 2
- LMXOHSDXUQEUSF-YECHIGJVSA-N sinefungin Chemical compound O[C@@H]1[C@H](O)[C@@H](C[C@H](CC[C@H](N)C(O)=O)N)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LMXOHSDXUQEUSF-YECHIGJVSA-N 0.000 claims 2
- 102100024840 snRNA-activating protein complex subunit 1 Human genes 0.000 claims 2
- 101710196646 snRNA-activating protein complex subunit 1 Proteins 0.000 claims 2
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 claims 2
- 230000035897 transcription Effects 0.000 claims 2
- 238000013518 transcription Methods 0.000 claims 2
- FKSFKBQGSFSOSM-QFIPXVFZSA-N 1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-[6-(1-piperazinyl)-3-pyridinyl]-4-indolecarboxamide Chemical compound C1=C2N([C@@H](C)CC)C=C(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=N1)=CC=C1N1CCNCC1 FKSFKBQGSFSOSM-QFIPXVFZSA-N 0.000 claims 1
- ZOIBZSZLMJDVDQ-UHFFFAOYSA-N 1-cyclopentyl-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-[4-(4-morpholinylmethyl)phenyl]-4-indazolecarboxamide Chemical compound O=C1NC(C)=CC(C)=C1CNC(=O)C1=CC(C=2C=CC(CN3CCOCC3)=CC=2)=CC2=C1C=NN2C1CCCC1 ZOIBZSZLMJDVDQ-UHFFFAOYSA-N 0.000 claims 1
- 108030002617 2'-5' oligoadenylate synthases Proteins 0.000 claims 1
- 102100035389 2'-5'-oligoadenylate synthase 3 Human genes 0.000 claims 1
- AXRCEOKUDYDWLF-UHFFFAOYSA-N 3-(1-methyl-3-indolyl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-3-indolyl]pyrrole-2,5-dione Chemical compound C12=CC=CC=C2N(C)C=C1C(C(NC1=O)=O)=C1C(C1=CC=CC=C11)=CN1C(CC1)CCN1CC1=CC=CC=N1 AXRCEOKUDYDWLF-UHFFFAOYSA-N 0.000 claims 1
- OMKHWTRUYNAGFG-IEBDPFPHSA-N 3-deazaneplanocin a Chemical compound C1=NC=2C(N)=NC=CC=2N1[C@@H]1C=C(CO)[C@@H](O)[C@H]1O OMKHWTRUYNAGFG-IEBDPFPHSA-N 0.000 claims 1
- ZLHFILGSQDJULK-UHFFFAOYSA-N 4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid Chemical compound C1=C(C(O)=O)C(OC)=CC(NC=2N=C3C4=CC=C(Cl)C=C4C(=NCC3=CN=2)C=2C(=CC=CC=2F)OC)=C1 ZLHFILGSQDJULK-UHFFFAOYSA-N 0.000 claims 1
- NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 claims 1
- XAUDJQYHKZQPEU-KVQBGUIXSA-N 5-aza-2'-deoxycytidine Chemical compound O=C1N=C(N)N=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 XAUDJQYHKZQPEU-KVQBGUIXSA-N 0.000 claims 1
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 claims 1
- PFHDWRIVDDIFRP-UHFFFAOYSA-N 6-cyano-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-pentan-3-ylindole-4-carboxamide Chemical compound C1=C(C#N)C=C2N(C(CC)CC)C=CC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O PFHDWRIVDDIFRP-UHFFFAOYSA-N 0.000 claims 1
- 102000004121 Annexin A5 Human genes 0.000 claims 1
- 108090000672 Annexin A5 Proteins 0.000 claims 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims 1
- 102000004000 Aurora Kinase A Human genes 0.000 claims 1
- 108090000461 Aurora Kinase A Proteins 0.000 claims 1
- 102100021631 B-cell lymphoma 6 protein Human genes 0.000 claims 1
- 239000012664 BCL-2-inhibitor Substances 0.000 claims 1
- 108091012583 BCL2 Proteins 0.000 claims 1
- 229940124291 BTK inhibitor Drugs 0.000 claims 1
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims 1
- 229940123711 Bcl2 inhibitor Drugs 0.000 claims 1
- 229940124292 CD20 monoclonal antibody Drugs 0.000 claims 1
- 102100021992 CD209 antigen Human genes 0.000 claims 1
- 101100164160 Caenorhabditis elegans atf-7 gene Proteins 0.000 claims 1
- 102000003952 Caspase 3 Human genes 0.000 claims 1
- 108090000397 Caspase 3 Proteins 0.000 claims 1
- 102000004041 Caspase 7 Human genes 0.000 claims 1
- 108090000567 Caspase 7 Proteins 0.000 claims 1
- 102000012422 Collagen Type I Human genes 0.000 claims 1
- 108010022452 Collagen Type I Proteins 0.000 claims 1
- 102300042968 Cyclic AMP-dependent transcription factor ATF-3 isoform 1 Human genes 0.000 claims 1
- 102100023578 Cyclic AMP-dependent transcription factor ATF-7 Human genes 0.000 claims 1
- 101710181881 Cyclic AMP-dependent transcription factor ATF-7 Proteins 0.000 claims 1
- 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 claims 1
- 101710157567 Cyclin-dependent kinase inhibitor 1 Proteins 0.000 claims 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 102100037964 E3 ubiquitin-protein ligase RING2 Human genes 0.000 claims 1
- 108091012458 E3 ubiquitin-protein ligase RING2 Proteins 0.000 claims 1
- 101710135573 E3 ubiquitin-protein ligase ZFP91 Proteins 0.000 claims 1
- 102100035075 ETS-related transcription factor Elf-1 Human genes 0.000 claims 1
- 101710131938 ETS-related transcription factor Elf-1 Proteins 0.000 claims 1
- 102100025137 Early activation antigen CD69 Human genes 0.000 claims 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 1
- 101710088167 Forkhead box protein J2 Proteins 0.000 claims 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 1
- 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 claims 1
- 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 claims 1
- 102100031000 Hepatoma-derived growth factor Human genes 0.000 claims 1
- 102100038970 Histone-lysine N-methyltransferase EZH2 Human genes 0.000 claims 1
- 101000597332 Homo sapiens 2'-5'-oligoadenylate synthase 3 Proteins 0.000 claims 1
- 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 claims 1
- 101600096911 Homo sapiens Cyclic AMP-dependent transcription factor ATF-3 (isoform 1) Proteins 0.000 claims 1
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 claims 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 1
- 101000882127 Homo sapiens Histone-lysine N-methyltransferase EZH2 Proteins 0.000 claims 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims 1
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 1
- 101000613625 Homo sapiens Lysine-specific demethylase 4A Proteins 0.000 claims 1
- 101000613629 Homo sapiens Lysine-specific demethylase 4B Proteins 0.000 claims 1
- 101001088883 Homo sapiens Lysine-specific demethylase 5B Proteins 0.000 claims 1
- 101000576320 Homo sapiens Max-binding protein MNT Proteins 0.000 claims 1
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 claims 1
- 101000593405 Homo sapiens Myb-related protein B Proteins 0.000 claims 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 1
- 101000809045 Homo sapiens Nucleolar transcription factor 1 Proteins 0.000 claims 1
- 101000613343 Homo sapiens Polycomb group RING finger protein 2 Proteins 0.000 claims 1
- 101001051767 Homo sapiens Protein kinase C beta type Proteins 0.000 claims 1
- 101000836084 Homo sapiens Serpin B7 Proteins 0.000 claims 1
- 101000909637 Homo sapiens Transcription factor COE1 Proteins 0.000 claims 1
- 101000825848 Homo sapiens snRNA-activating protein complex subunit 4 Proteins 0.000 claims 1
- 102100022338 Integrin alpha-M Human genes 0.000 claims 1
- 101710127454 Interferon alpha-3 Proteins 0.000 claims 1
- 102000006992 Interferon-alpha Human genes 0.000 claims 1
- 108010047761 Interferon-alpha Proteins 0.000 claims 1
- 102000003996 Interferon-beta Human genes 0.000 claims 1
- 108090000467 Interferon-beta Proteins 0.000 claims 1
- 102000008070 Interferon-gamma Human genes 0.000 claims 1
- 108010074328 Interferon-gamma Proteins 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 229940121730 Janus kinase 2 inhibitor Drugs 0.000 claims 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- 239000002144 L01XE18 - Ruxolitinib Substances 0.000 claims 1
- 239000002177 L01XE27 - Ibrutinib Substances 0.000 claims 1
- 102000017578 LAG3 Human genes 0.000 claims 1
- UIARLYUEJFELEN-LROUJFHJSA-N LSM-1231 Chemical compound C12=C3N4C5=CC=CC=C5C3=C3C(=O)NCC3=C2C2=CC=CC=C2N1[C@]1(C)[C@](CO)(O)C[C@H]4O1 UIARLYUEJFELEN-LROUJFHJSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 101710105761 Lysine-specific demethylase 4A Proteins 0.000 claims 1
- 101710105773 Lysine-specific demethylase 4B Proteins 0.000 claims 1
- 101710105712 Lysine-specific demethylase 5B Proteins 0.000 claims 1
- 101710128155 Max-binding protein MNT Proteins 0.000 claims 1
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 claims 1
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 claims 1
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 claims 1
- 101100351020 Mus musculus Pax5 gene Proteins 0.000 claims 1
- 102100034670 Myb-related protein B Human genes 0.000 claims 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 1
- JOOXLOJCABQBSG-UHFFFAOYSA-N N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide Chemical compound N1=C(NC=2C=C(C=CC=2)S(=O)(=O)NC(C)(C)C)C(C)=CN=C1NC(C=C1)=CC=C1OCCN1CCCC1 JOOXLOJCABQBSG-UHFFFAOYSA-N 0.000 claims 1
- 206010028851 Necrosis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 102100038485 Nucleolar transcription factor 1 Human genes 0.000 claims 1
- 239000012828 PI3K inhibitor Substances 0.000 claims 1
- 102100037504 Paired box protein Pax-5 Human genes 0.000 claims 1
- 101710149067 Paired box protein Pax-5 Proteins 0.000 claims 1
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 claims 1
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 claims 1
- 102100040919 Polycomb group RING finger protein 2 Human genes 0.000 claims 1
- 108010022429 Polycomb-Group Proteins Proteins 0.000 claims 1
- 102000012425 Polycomb-Group Proteins Human genes 0.000 claims 1
- 102100035251 Protein C-ets-1 Human genes 0.000 claims 1
- 101710204015 Protein C-ets-1 Proteins 0.000 claims 1
- 102100024923 Protein kinase C beta type Human genes 0.000 claims 1
- 102000009572 RNA Polymerase II Human genes 0.000 claims 1
- 108010009460 RNA Polymerase II Proteins 0.000 claims 1
- 102100025521 Serpin B7 Human genes 0.000 claims 1
- 108010002687 Survivin Proteins 0.000 claims 1
- 101710182998 Transcription factor COE1 Proteins 0.000 claims 1
- 101100351021 Xenopus laevis pax5 gene Proteins 0.000 claims 1
- 229950009821 acalabrutinib Drugs 0.000 claims 1
- WDENQIQQYWYTPO-IBGZPJMESA-N acalabrutinib Chemical compound CC#CC(=O)N1CCC[C@H]1C1=NC(C=2C=CC(=CC=2)C(=O)NC=2N=CC=CC=2)=C2N1C=CN=C2N WDENQIQQYWYTPO-IBGZPJMESA-N 0.000 claims 1
- 108091006088 activator proteins Proteins 0.000 claims 1
- 229950009447 alisertib Drugs 0.000 claims 1
- 230000004075 alteration Effects 0.000 claims 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 claims 1
- 150000004056 anthraquinones Chemical class 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 claims 1
- 229960002756 azacitidine Drugs 0.000 claims 1
- 229950000971 baricitinib Drugs 0.000 claims 1
- XUZMWHLSFXCVMG-UHFFFAOYSA-N baricitinib Chemical compound C1N(S(=O)(=O)CC)CC1(CC#N)N1N=CC(C=2C=3C=CNC=3N=CN=2)=C1 XUZMWHLSFXCVMG-UHFFFAOYSA-N 0.000 claims 1
- 229960002707 bendamustine Drugs 0.000 claims 1
- YTKUWDBFDASYHO-UHFFFAOYSA-N bendamustine Chemical compound ClCCN(CCCl)C1=CC=C2N(C)C(CCCC(O)=O)=NC2=C1 YTKUWDBFDASYHO-UHFFFAOYSA-N 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000021164 cell adhesion Effects 0.000 claims 1
- 230000022131 cell cycle Effects 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 229960000684 cytarabine Drugs 0.000 claims 1
- 210000000805 cytoplasm Anatomy 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 229960003603 decitabine Drugs 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- 229960003957 dexamethasone Drugs 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- 229950002189 enzastaurin Drugs 0.000 claims 1
- 230000001973 epigenetic effect Effects 0.000 claims 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 claims 1
- 229960005420 etoposide Drugs 0.000 claims 1
- 229960005167 everolimus Drugs 0.000 claims 1
- 210000002744 extracellular matrix Anatomy 0.000 claims 1
- 229950003487 fedratinib Drugs 0.000 claims 1
- 229950005309 fostamatinib Drugs 0.000 claims 1
- GKDRMWXFWHEQQT-UHFFFAOYSA-N fostamatinib Chemical compound COC1=C(OC)C(OC)=CC(NC=2N=C(NC=3N=C4N(COP(O)(O)=O)C(=O)C(C)(C)OC4=CC=3)C(F)=CN=2)=C1 GKDRMWXFWHEQQT-UHFFFAOYSA-N 0.000 claims 1
- 101150051296 foxj2 gene Proteins 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 108010052188 hepatoma-derived growth factor Proteins 0.000 claims 1
- 229940121372 histone deacetylase inhibitor Drugs 0.000 claims 1
- 239000003276 histone deacetylase inhibitor Substances 0.000 claims 1
- 229940075628 hypomethylating agent Drugs 0.000 claims 1
- 229960001507 ibrutinib Drugs 0.000 claims 1
- XYFPWWZEPKGCCK-GOSISDBHSA-N ibrutinib Chemical compound C1=2C(N)=NC=NC=2N([C@H]2CN(CCC2)C(=O)C=C)N=C1C(C=C1)=CC=C1OC1=CC=CC=C1 XYFPWWZEPKGCCK-GOSISDBHSA-N 0.000 claims 1
- 229960003445 idelalisib Drugs 0.000 claims 1
- YKLIKGKUANLGSB-HNNXBMFYSA-N idelalisib Chemical compound C1([C@@H](NC=2[C]3N=CN=C3N=CN=2)CC)=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1 YKLIKGKUANLGSB-HNNXBMFYSA-N 0.000 claims 1
- 229960001101 ifosfamide Drugs 0.000 claims 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 claims 1
- 230000006882 induction of apoptosis Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 229960003130 interferon gamma Drugs 0.000 claims 1
- 229960001388 interferon-beta Drugs 0.000 claims 1
- 229940043355 kinase inhibitor Drugs 0.000 claims 1
- 229950001845 lestaurtinib Drugs 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 210000003563 lymphoid tissue Anatomy 0.000 claims 1
- 229940124302 mTOR inhibitor Drugs 0.000 claims 1
- 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960001924 melphalan Drugs 0.000 claims 1
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- ZVHNDZWQTBEVRY-UHFFFAOYSA-N momelotinib Chemical compound C1=CC(C(NCC#N)=O)=CC=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCOCC2)=N1 ZVHNDZWQTBEVRY-UHFFFAOYSA-N 0.000 claims 1
- 229950008814 momelotinib Drugs 0.000 claims 1
- 208000025113 myeloid leukemia Diseases 0.000 claims 1
- NSQSAUGJQHDYNO-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide Chemical compound C=1C(C=2C=CC(CN3CCOCC3)=CC=2)=CC(C(=O)NCC=2C(NC(C)=CC=2C)=O)=C(C)C=1N(CC)C1CCOCC1 NSQSAUGJQHDYNO-UHFFFAOYSA-N 0.000 claims 1
- HPODOLXTMDHLLC-QGZVFWFLSA-N n-[(4-methoxy-6-methyl-2-oxo-1h-pyridin-3-yl)methyl]-2-methyl-1-[(1r)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C3=CC=CC=C3N([C@H](C)C3CCN(CC(F)(F)F)CC3)C=2C)=C1OC HPODOLXTMDHLLC-QGZVFWFLSA-N 0.000 claims 1
- DPJNKUOXBZSZAI-UHFFFAOYSA-N n-[(6-methyl-2-oxo-4-propyl-1h-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3C=NN(C=3C=C(C=2)C=2C=NC(=CC=2)N2CCN(CC2)C(C)C)C(C)C)=C1CCC DPJNKUOXBZSZAI-UHFFFAOYSA-N 0.000 claims 1
- 230000017074 necrotic cell death Effects 0.000 claims 1
- 229960001756 oxaliplatin Drugs 0.000 claims 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims 1
- 229950011410 pacritinib Drugs 0.000 claims 1
- HWXVIOGONBBTBY-ONEGZZNKSA-N pacritinib Chemical compound C=1C=C(C=2)NC(N=3)=NC=CC=3C(C=3)=CC=CC=3COC\C=C\COCC=2C=1OCCN1CCCC1 HWXVIOGONBBTBY-ONEGZZNKSA-N 0.000 claims 1
- 229960005184 panobinostat Drugs 0.000 claims 1
- FWZRWHZDXBDTFK-ZHACJKMWSA-N panobinostat Chemical compound CC1=NC2=CC=C[CH]C2=C1CCNCC1=CC=C(\C=C\C(=O)NO)C=C1 FWZRWHZDXBDTFK-ZHACJKMWSA-N 0.000 claims 1
- 229940043441 phosphoinositide 3-kinase inhibitor Drugs 0.000 claims 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 claims 1
- 229960003452 romidepsin Drugs 0.000 claims 1
- OHRURASPPZQGQM-UHFFFAOYSA-N romidepsin Natural products O1C(=O)C(C(C)C)NC(=O)C(=CC)NC(=O)C2CSSCCC=CC1CC(=O)NC(C(C)C)C(=O)N2 OHRURASPPZQGQM-UHFFFAOYSA-N 0.000 claims 1
- 108010091666 romidepsin Proteins 0.000 claims 1
- 229960000215 ruxolitinib Drugs 0.000 claims 1
- HFNKQEVNSGCOJV-OAHLLOKOSA-N ruxolitinib Chemical compound C1([C@@H](CC#N)N2N=CC(=C2)C=2C=3C=CNC=3N=CN=2)CCCC1 HFNKQEVNSGCOJV-OAHLLOKOSA-N 0.000 claims 1
- 229950008974 sinefungin Drugs 0.000 claims 1
- 102100022780 snRNA-activating protein complex subunit 4 Human genes 0.000 claims 1
- 230000003319 supportive effect Effects 0.000 claims 1
- 229950004774 tazemetostat Drugs 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- LQBVNQSMGBZMKD-UHFFFAOYSA-N venetoclax Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 LQBVNQSMGBZMKD-UHFFFAOYSA-N 0.000 claims 1
- 229960001183 venetoclax Drugs 0.000 claims 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 1
- 229960004528 vincristine Drugs 0.000 claims 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 1
- WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 claims 1
- 229960000237 vorinostat Drugs 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962924044P | 2019-10-21 | 2019-10-21 | |
US62/924,044 | 2019-10-21 | ||
PCT/US2020/056431 WO2021080950A1 (en) | 2019-10-21 | 2020-10-20 | Methods for treating a hematological cancer and the use of companion biomarkers for 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022552883A JP2022552883A (ja) | 2022-12-20 |
JPWO2021080950A5 true JPWO2021080950A5 (pt) | 2023-12-08 |
Family
ID=75490827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022523522A Pending JP2022552883A (ja) | 2019-10-21 | 2020-10-20 | 血液がんの治療方法ならびに2-(2,6-ジオキソピペリジン-3-イル)-4-((2-フルオロ-4-((3-モルホリノアゼチジン-1-イル)メチル)ベンジル)アミノ)イソインドリン-1,3-ジオンに対するコンパニオンバイオマーカーの使用 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20210116454A1 (pt) |
EP (1) | EP4048668A4 (pt) |
JP (1) | JP2022552883A (pt) |
KR (1) | KR20220103949A (pt) |
CN (1) | CN115175903A (pt) |
AU (1) | AU2020372333A1 (pt) |
BR (1) | BR112022007386A2 (pt) |
CA (1) | CA3154890A1 (pt) |
IL (1) | IL292305A (pt) |
MX (1) | MX2022004688A (pt) |
WO (1) | WO2021080950A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202415665A (zh) | 2022-06-06 | 2024-04-16 | 美商樹線生物科學公司 | 三環喹啉酮bcl6雙功能降解劑 |
WO2023244917A1 (en) | 2022-06-13 | 2023-12-21 | Treeline Biosciences, Inc. | 1,8-naphthyridin-2-one heterobifunctional bcl6 degraders |
WO2023244918A1 (en) | 2022-06-13 | 2023-12-21 | Treeline Biosciences, Inc. | Quinolone bcl6 bifunctional degraders |
CN115261469B (zh) * | 2022-06-23 | 2023-03-31 | 山东第一医科大学附属省立医院(山东省立医院) | Brd9在慢性淋巴细胞白血病诊治中的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200901852B (en) * | 2006-09-15 | 2010-06-30 | Celgene Corp | N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
CA2834535A1 (en) * | 2011-04-29 | 2012-11-01 | Celgene Corporation | Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor |
EP2867671B1 (en) * | 2012-06-29 | 2018-10-24 | Celgene Corporation | Methods for determining drug efficacy using cereblon-associated proteins |
CN118547067A (zh) * | 2013-03-15 | 2024-08-27 | 豪夫迈·罗氏有限公司 | 治疗pd-1和pd-l1相关疾患的生物标志物和方法 |
BR112016012792A2 (pt) * | 2013-12-06 | 2017-08-08 | Celgene Corp | Métodos para o tratamento de cânceres hematológicos e o uso de biomarcadores como um preditor de sensibilidade clínica a terapias imunomoduladoras |
JP7001614B2 (ja) * | 2016-04-06 | 2022-02-03 | ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン | リガンド依存性の標的タンパク質分解のための単官能性中間体 |
US20200054639A1 (en) * | 2016-10-31 | 2020-02-20 | Oregon Health & Science University | Combinations of agents to treat hematological malignancies |
DK3784663T3 (da) * | 2018-04-23 | 2023-10-16 | Celgene Corp | Substituerede 4-aminoisoindolin-1,3-dionforbindelser og deres anvendelse til behandlng af et lymfom |
AR119715A1 (es) * | 2019-04-12 | 2022-01-05 | Celgene Corp | Métodos para tratar linfoma no hodgkin con el uso de 2-(2,6-dioxopiperidin-3-il)-4-((2-fluoro-4-((3-morfolinoazetidin-1-il)metil)bencil)amino)isoindolin-1,3-diona |
-
2020
- 2020-10-20 MX MX2022004688A patent/MX2022004688A/es unknown
- 2020-10-20 BR BR112022007386A patent/BR112022007386A2/pt unknown
- 2020-10-20 US US17/075,594 patent/US20210116454A1/en active Pending
- 2020-10-20 WO PCT/US2020/056431 patent/WO2021080950A1/en unknown
- 2020-10-20 AU AU2020372333A patent/AU2020372333A1/en active Pending
- 2020-10-20 KR KR1020227016732A patent/KR20220103949A/ko unknown
- 2020-10-20 CN CN202080089983.4A patent/CN115175903A/zh active Pending
- 2020-10-20 EP EP20879791.0A patent/EP4048668A4/en active Pending
- 2020-10-20 JP JP2022523522A patent/JP2022552883A/ja active Pending
- 2020-10-20 CA CA3154890A patent/CA3154890A1/en active Pending
- 2020-10-20 IL IL292305A patent/IL292305A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tew et al. | Association between response to etrolizumab and expression of integrin αE and granzyme A in colon biopsies of patients with ulcerative colitis | |
Grandis et al. | Retinoic acid normalizes the increased gene transcription rate of TGF–α and EGFR in head and neck cancer cell lines | |
US11579140B2 (en) | Methods related to bronchial premalignant lesion severity and progression | |
EP3325661B1 (en) | Fgfr expression and susceptibility to an fgfr inhibitor | |
Guenterberg et al. | Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis | |
WO2018184003A1 (en) | Modulating dsrna editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferon | |
Lee et al. | Gene expression profile in interleukin-4-stimulated human vascular endothelial cells | |
JP2005512961A5 (pt) | ||
US20210116454A1 (en) | Methods for treating a hematological cancer and the use of companion biomarkers for 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione | |
KR20180026215A (ko) | 방사선 피폭 진단용 조성물 및 이를 이용한 방사선 피폭 진단방법 | |
Srivastava et al. | Age and gender related differences in human parotid gland gene expression | |
Vergara et al. | Genetic drivers of non‐cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape | |
Pettiette et al. | MicroRNA expression profiles in external cervical resorption | |
Li et al. | Targeting transcription factors in multiple myeloma: evolving therapeutic strategies | |
WO2016201365A2 (en) | Methods for treating cancers | |
Hinshaw et al. | Hedgehog signaling regulates Treg to Th17 conversion through metabolic rewiring in breast cancer | |
Thomas et al. | Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review | |
JPWO2021080950A5 (pt) | ||
EP2904108B1 (en) | Methods for predicting multiple myeloma treatment response | |
WO2015157247A1 (en) | Compositions and methods related to dormant senescence-prone cells (dspc) | |
US20220242955A1 (en) | Targeting galectin-9 as a therapeutic strategy for t-cell exhaustion in t-cell acute lymphoblastic leukemia | |
Drieux et al. | How molecular advances may improve the diagnosis and management of PTCL patients | |
ES2971091T3 (es) | Un método para supervisar las respuestas farmacodinámicas mediadas por la administración de glucocorticoides in vivo | |
Zimmerer et al. | IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m2 | |
Alawadi | Interleukin-6 level among Iraqi patients with chronic lymphocytic leukemia from Babil Province |